Surviving Biliary Sepsis: Unveiling 90-Day Mortality and Risks

Surviving biliary sepsis: A retrospective study in a cancer center unveils a 30.3% 90-day mortality rate, with factors like metastatic stage, biliary tract tumor compression, and multi-drug resistant bacteria influencing outcomes. Antibiotic de-escalation emerges as a safe strategy, linked with better survival. Beyond organ dysfunctions, the study emphasizes the impact of cancer stage, bacteria colonization, and performance status on mortality. In the world of biliary sepsis, navigating factors and antibiotic strategies becomes crucial for a favorable 90-day survival.